Pegavision Asset Resilience Ratio
Pegavision asset resilience ratio. Pegavision (6491) has an Asset Resilience Ratio of 17.14% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Pegavision (6491) total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Pegavision (2012–2025)
Asset resilience ratio of Pegavision from 2012 to 2025. This chart shows how Pegavision's Asset Resilience Ratio has changed over time. See Pegavision (6491) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Liquid Assets Composition Over Time
This chart breaks down Pegavision's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see total assets of Pegavision.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 0% |
| Short-term Investments | NT$2.77 Billion | 17.14% |
| Total Liquid Assets | NT$2.77 Billion | 17.14% |
Asset Resilience Insights
- Good Liquidity Position: Pegavision maintains a healthy 17.14% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
Pegavision Industry Peers by Asset Resilience Ratio
Compare Pegavision's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Nyxoah
BR:NYXH |
Medical Instruments & Supplies | 12.40% |
|
Ocumetics Technology Corp
V:OTC |
Medical Instruments & Supplies | 0.00% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 7.53% |
|
Nanosonics Ltd
AU:NAN |
Medical Instruments & Supplies | 46.84% |
|
SDI Ltd
AU:SDI |
Medical Instruments & Supplies | 3.36% |
|
Austco Healthcare Ltd
AU:AHC |
Medical Instruments & Supplies | 15.90% |
|
Trajan Group Holdings Ltd
AU:TRJ |
Medical Instruments & Supplies | 0.29% |
|
Osteopore Ltd
AU:OSX |
Medical Instruments & Supplies | 22.60% |
Pegavision Asset Resilience Ratio by Year (2012–2025)
Pegavision asset resilience ratio by year from 2012 to 2025. The table below shows the annual Asset Resilience Ratio data for Pegavision.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 17.14% | NT$2.77 Billion ≈ $87.35 Million |
NT$16.17 Billion ≈ $509.58 Million |
+1.63pp |
| 2024-12-31 | 15.51% | NT$2.26 Billion ≈ $71.09 Million |
NT$14.55 Billion ≈ $458.27 Million |
-18.65pp |
| 2023-12-31 | 34.16% | NT$4.73 Billion ≈ $149.14 Million |
NT$13.86 Billion ≈ $436.63 Million |
+27.19pp |
| 2022-12-31 | 6.97% | NT$666.49 Million ≈ $21.00 Million |
NT$9.56 Billion ≈ $301.24 Million |
+6.19pp |
| 2021-12-31 | 0.78% | NT$67.03 Million ≈ $2.11 Million |
NT$8.56 Billion ≈ $269.84 Million |
-8.05pp |
| 2020-12-31 | 8.83% | NT$566.77 Million ≈ $17.86 Million |
NT$6.42 Billion ≈ $202.14 Million |
+2.88pp |
| 2019-12-31 | 5.95% | NT$316.12 Million ≈ $9.96 Million |
NT$5.31 Billion ≈ $167.28 Million |
+4.14pp |
| 2018-12-31 | 1.82% | NT$75.28 Million ≈ $2.37 Million |
NT$4.15 Billion ≈ $130.67 Million |
-2.72pp |
| 2017-12-31 | 4.53% | NT$131.91 Million ≈ $4.16 Million |
NT$2.91 Billion ≈ $91.66 Million |
-17.12pp |
| 2016-12-31 | 21.66% | NT$417.44 Million ≈ $13.15 Million |
NT$1.93 Billion ≈ $60.72 Million |
+16.51pp |
| 2014-12-31 | 5.15% | NT$80.89 Million ≈ $2.55 Million |
NT$1.57 Billion ≈ $49.48 Million |
+2.12pp |
| 2013-12-31 | 3.03% | NT$31.26 Million ≈ $984.74K |
NT$1.03 Billion ≈ $32.52 Million |
-2.12pp |
| 2012-12-31 | 5.15% | NT$80.89 Million ≈ $2.55 Million |
NT$1.57 Billion ≈ $49.48 Million |
-- |
About Pegavision
Pegavision Corporation manufactures and sells medical devices, and optical and precision instruments in Taiwan. It offers soft contact lenses. The company was founded in 2009 and is based in Taoyuan City, Taiwan. Pegavision Corporation is a subsidiary of Kinsus Interconnect Technology Corp.